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Introduction
Biological stress is a response to physical, chemical, biological
and emotional changes, consisting of a pattern of metabolic
and behavioral reactions that helps to strengthen the organism
(1). During stressful situations, the energy requirement of the
organism is increased, resulting in enhanced generation of free
radicals (2–4). Free radicals cause oxidation of nucleic acids
and proteins. Free radicals also damage biomembranes,
reflected by increased lipid peroxidation, thereby compromis-
ing cell integrity and function. During this process, the ability
of the body’s defense system to combat the oxidative stress
may diminish due to reduced anti-oxidants. If the stress level
increases beyond the threshold limit of an individual, it results
in decreased performance and stress-induced disorders.
The management of unusual stress therefore has acquired
enormous significance in day-to-day life. Such a management
does not endeavor to eliminate stress but rather to raise the
threshold level of the organism beyond which stress would
start injuring and disturbing life processes. It is possible to
support the body’s adaptation by using food supplements,
dietary elements, herbs and minerals for increasing physical
and mental performance, described in various oriental sys-
tems of medicine including the ancient Indian medical
system Ayurveda. Such substances have been described as
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performance of the organism is dependent on the availability
of appropriate macro- and micronutrients required in excess on
account of their increased utilization during stressful situations
(6). Supplementation with various macro- and micronutrient
and herbal preparations has been evaluated for their
adaptogenic activity during exposure to a stressful environ-
ment (7–10).
It has been suggested that amino acid supplementation might
be able to increase human performance to a limited extent
(11). An amino acid mixture supplementation was observed
to enhance adrenocortical hormone, luteinizing hormone and
follicle-stimulating hormone response to corticotropin-
releasing hormone in athletes (12). Under certain metabolic,
developmental or pathophysiological conditions, some of the
non-essential amino acids become essential and are designated
as ‘conditionally essential’. Arginine and glutamine are known
to be conditionally essential amino acids (13). L-Arginine
plays important roles in the urea cycle, protein synthesis, as a
precursor of polyamines and creatine, and as a substrate for
synthesis of nitric oxide (NO). NO was shown to be an
endothelial-derived relaxation factor, a vasodilator, which acted
as a modulator of vascular tone to regulate blood flow and
blood pressure (14). NO is also involved in enhancement of
the thermogenic function of brown adipose tissue in rats (15).
It is interesting that herbs with adaptogenic activity, e.g.
Panax ginseng, have been shown to contain large amounts of
arginine (16).
It was shown that endogenous plasma arginine levels
decreased significantly after 30 min immobilization stress and
remain suppressed during a 3.5 h post-stress period (17). In
burn patients, there was a higher rate of arginine loss from the
body and supplementation of arginine was required to maintain
homeostasis and promote recovery (18). In the present study, the
anti-stress and adaptogenic effect, if any, of L-arginine supple-
mentation was studied in rats subjected to a comprehensive
and generalized stress of cold (5 C)–hypoxia (428 mmHg)–
restraint (C-H-R) (19).
Materials and Methods
Rats and Maintenance
Randomly bred, healthy, adult albino rats of the Wistar strain,
weighing 180   20 g, from the animal colony of the Defence
Institute of Physiology and Allied Sciences, Delhi, India, were
used in this study. The experimental protocol was submitted to
the animal ethics committee of the institute, and approval was
obtained for conducting the experiments. The rats were kept in
a room that was maintained at 25   1 C with natural daylight.
The room remained dark from 7 p.m. until 7 a.m. in the morn-
ing. The animals had free access to drinking water and food in
pellet form (Lipton India Ltd., Calcutta, India). All the experi-
ments were done on overnight fasted rats. The L-arginine used
in the study was obtained from Sigma Chemical Company,
St Louis, MO.
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Experimental Design
In the present study, two experiments were carried out, one for
dose-dependent study of L-arginine supplementation in rats
using the C-H-R animal model to evaluate the least effective
dose for adaptogenic activity and another for studying
biochemical parameters in animals administered the least
effective single oral dose of L-arginine.
Dose-dependent Studies
In total, 42 overnight fasted Wistar strain male rats were used
in this experiment. The L-arginine was dissolved in distilled
water in the appropriate concentration. A single dose of L-
arginine was given orally in a 0.5 ml volume through a gastric
cannula to overnight fasted rats, 30 min prior to C-H-R exposure
(19). The L-arginine doses studied were 12.5, 25, 50, 100, 200
and 500 mg/kg body weight. Six rats were used for each dose.
Six control rats were administered an equivalent amount of
water orally 30 min prior to C-H-R exposure. The rats were
exposed in a decompression chamber maintained at 5 C and a
low atmospheric pressure of 428 mmHg pressure equivalent to
an altitude of 4572 m. The rats were restrained and a rectal
probe was inserted 2 cm past the rectum and kept there with
the help of adhesive plaster. The rectal temperature (Trec) of the
rats was monitored once per minute, by using a 16-channel
Isothermex Temperature Recorder (Columbus Instrument,
Columbus, OH). When the rats attained a rectal temperature
(Trec) of 23 C, they were taken out of the chamber. The rats
were allowed to recover to a normal Trec of 37 C at normal
atmospheric pressure and ambient temperature 32   1 C. The
rats continued to be restrained during the recovery period.
Although the comfortable temperature for housing the animals
was 25   1 C, the temperature for recovery of Trec (37 C) was
selected as 32   1 C because this was close to the ambient
temperature of the outside environment. A constant room
temperature was maintained in all experiments as recovery time
also depended on the ambient temperature. The time taken to
attain Trec 23 C and its recovery to 37 C were used as a meas-
ure of endurance.
Biochemical Analysis
In the second experiment, 36 separate overnight fasted rats
were used. Rats were divided into two groups, containing
18 rats in each. One group was given the least effective dose of
L-arginine and the other served as control. Both arginine-
treated and control rats were subdivided further into three
groups, six rats in each group: (i) rats not exposed to C-H-R;
(ii) rats exposed to C-H-R to a fall of Trec to 23 C; and (iii) rats
exposed to C-H-R and recovered to Trec 37 C.
A single oral dose of L-arginine was administered orally to
rats in a 0.5 ml volume, 30 min prior to C-H-R exposure. In
control rats, the equivalent volume of water was administered
orally 30 min prior to C-H-R exposure. About 4 ml of blood
was collected from the orbital plexus of the eye, in heparinized
tubes, of different group of rats both control and arginineeCAM 2005;2(1) 95
treated (exposed and unexposed) under mild ether anesthesia, on
attaining both Trec 23 C and Trec 37 C. A portion of blood was
used to separate the plasma. Malondialdehyde (MDA), a marker
for lipid peroxidation, was measured in plasma by the method
of Dousset et al. (20). Blood levels of lactate dehydrogenase
(LDH), as a marker of cell membrane permeability, were esti-
mated (21). In plasma, the levels of nitric oxide (NO), as a
metabolite of nitrite and nitrate, were measured using diagnostic
kits obtained from Oxis International Inc., Portland, OR. Plasma
levels of testosterone, a stress marker (29), were estimated using
the radioimmunoassay kits obtained from Immunotech, Marseille,
Cedex, France. In blood, superoxide dismutase (SOD) was esti-
mated by the method of Marklund (22), catalase (CAT) by the
method of Aebi et al, (23) and reduced glutathione (GSH) by the
method of Beutler et al. (24). In blood and plasma, protein was
estimated by the method of Lowry et al. (25) for calculating the
specific activity of the enzymes.
Statistics
The results were analyzed using one-way analysis of variance
(ANOVA) for their statistical significance and expressed as the
mean   SEM. The results of L-arginine-treated animals were
compared with the respective controls and P-values   0.05
were considered statistically significant.
Results
Dose-dependent Studies
The orally administered doses of 12.5, 25 and 50 mg/kg body
weight in rats were observed to have no significant effect on
the time taken to attain Trec 23 C in comparison with controls.
However, L-arginine doses of 100, 200 and 500 mg/kg body
weight showed a significant increase in time taken to attain a
fall of Trec to 23 C. The time taken by the rats to recover Trec
37 C from C-H-R-induced hypothermia was reduced signifi-
cantly at all the doses of L-arginine used, except the 500 mg/kg
body weight dose in comparison with control rats (Fig. 1).
However, the oral administration of L-arginine at a dose of
100 mg/kg body weight was observed to possess an optimum
adaptogenic activity as evidenced by a significant increase
(53.5%) in the time taken to attain a fall of Trec to 23 C and
significantly faster (39.6%) recovery (Trec 37 C) from C-H-R
exposure-induced hypothermia, in comparison with control
rats (Fig. 1).
Plasma MDA and Anti-oxidants
The results regarding the oxidative stress, i.e. TBA-reactive
MDA levels and some of the circulating anti-oxidants (SOD,
CAT and GSH), of rats exposed to C-H-R stress with and without
prior intake of a single oral dose of L-arginine of 100 mg/kg body
weight (least effective dose) are shown in Table 1. Plasma MDA
showed a 19% increase in control rats on attaining Trec 23 C dur-
ing C-H-R exposure, but supplementation of L-arginine resulted
in MDA levels comparable with control values. In control rats
exposed to C-H-R, blood SOD levels showed a non-significant
decrease on attaining Trec 23 C, but increased significantly
on recovery (Trec 37 C).  L-Arginine administration resulted
in increased SOD levels in rats on attaining Trec 23 C, in
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Figure 1. Dose-dependent study of L-arginine in rats on time (in minutes)
taken to attain Trec 23 C during C-H-R exposure and recovery of rectal
temperature to 37 C.     Trec 20 C     Trec 37 C. *Significant in comparison
with their respective control values at P   0.05.
Table 1. L-Arginine (100 mg/kg) supplementation and plasma MDA and blood SOD, GSH and CAT levels
n Control L-Arginine-treated
Unexposed Exposed Unexposed Exposed
Trec 23 C Trec 37 C Trec 23 C Trec 37 C
MDA ( mol/l) 6 0.95   0.1 1.13   0.1* 1.02   0.06 0.93   0.04 0.76   0.08* 0.73   0.21
SOD (U/mg protein) 6 4.72   0.44 4.27   0.49 6.4   0.45* 4.88   0.27 6.46   0.32* 5.72   0.12*
CAT (U/mg protein) 6 15.4   0.9 11.2   1.3* 9.42   0.8* 12.4   0.8 11.8   0.9 11.4   0.8
GSH (mg %) 6 21.67   2.1 20.32   1.9 21.46   1.6 20.53   1.4 24.13   2.3 19.76   1.2
*Significant in comparison with their respective unexposed groups at P   0.05.96 Anti-stress and adaptogenic activity of L-arginine
Table 2. L-Arginine supplementation and circulating level of blood LDH, plasma NO and testosterone levels
n Control L-Arginine-treated
Unexposed Exposed Unexposed Exposed
Trec 23 C Trec 37 C Trec 23 C Trec 37 C
LDH 6 24.8   3.7 39.3   4.7* 50.9   4.9* 32.5   6.7 47.3   3.9* 39.5   4.8
(nmol/mg protein)
NO ( M) 6 3.47   0.7 2.92   0.5 2.74   0.4 3.57   0.5 3.82   0.6 2.90   0.5
Testosterone (ng/ml) 6 2.62   0.80 0.43   0.02* 0.23   0.01* 2.58   0.70 0.53   0.02* 0.42   0.02*
*Significant in comparison with their respective unexposed groups at P   0.05.
comparison with the respective unexposed rats. The blood CAT
activity in control rats exposed to C-H-R decreased on attaining
Trec 23 C and on recovery (Trec 37 C), in comparison with unex-
posed rats. However, in rats administered L-arginine, blood CAT
activity was comparable with the respective unexposed animals,
both on attaining Trec 23 C and on recovery (Trec 37 C). No sig-
nificant change was observed in the GSH levels of control rats on
attaining Trec 23 C during C-H-R exposure and on recovery of
Trec 37 C. The L-arginine administration had no significant effect
on blood GSH levels.
Blood LDH and Plasma NO and Testosterone
The results of the blood LDH and plasma NO and testosterone
levels are shown in Table 2. In control rats, blood LDH levels
increased significantly (58%) on attaining Trec 23 C during 
C-H-R exposure and on recovery (105%) of Trec 37 C, in com-
parison with unexposed control rats. In rats administered 
L-arginine, the increase in blood LDH levels was less compared
with controls (45.3 versus 58.5%, and 21.5 versus 105.2%)
both on attaining Trec 23 C and on recovery of Trec 37 C
(Table 2). In control and L-arginine-treated rats, there was no
change in the plasma NO levels on attaining Trec 23 C and
recovery of Trec 37 C in comparison with the respective unex-
posed rats (Table 3). Plasma testosterone levels decreased sig-
nificantly in both control and L-arginine-treated rats on
attaining Trec 23 C and on recovery of Trec 37 C, in comparison
with unexposed rats. The decrease was comparatively less in 
L-arginine-treated rats (Table 2).
Discussion
Dose-dependent studies were performed using a passive C-H-R
animal model. In the C-H-R animal model, the time taken to
attain  Trec 23 C indicates exhaustion of the animal’s energy
resources or resistance to stress, and the time taken to recover
Trec 37 C from C-H-R exposure-induced hypothermia (Trec
23 C), at normal atmospheric pressure and 32 C ambient
temperature, indicates how fast the post-stress recovery of the
animal is. The results of the dose-dependent study showed that
for the two orally administered L-arginine doses (100 and
200 mg/kg body weight), the time taken to attain Trec 23 C and
recovery (Trec 37 C) from C-H-R exposure-induced hypother-
mia was almost comparable. With the 100 mg dose, the stress
resistance effect (i.e. the time taken to attain Trec 23 C) was
slightly better than for the 200 mg/kg dose, while with the
200 mg/kg dose, the post-stress recovery effect was slightly
better than with the 100 mg/kg body weight dose. This
suggested that both the doses, i.e. 100 and 200 mg/kg, were
effective. Hence out of these two doses of L-arginine, the lowest
one, i.e. 100 mg/kg, was selected as the least effective anti-
stress and adaptogenic dose. The L-arginine dose of 100 mg/kg
body weight was used further to study the effect of L-arginine
administration on some of the biochemical indices related to
oxidative stress, NO levels and cell membrane permeability.
Hypoxia, cold and immobilization stressors present in the 
C-H-R animal model used are known to produce oxidative
stress (2–4) and skeletal muscle fatigue (26). Free radicals
cause oxidation of lipids, proteins and bases of nucleic acids.
Free radicals also cause damage to biomembranes, reflected by
lipid peroxidation, thereby compromising cell integrity and
function. In the present study, plasma MDA levels also
increased in control rats on attaining Trec 23 C during C-H-R
exposure along with decreased blood CAT, suggesting oxida-
tive stress. However, GSH and SOD levels showed no change
on attaining Trec 23 C during C-H-R exposure; perhaps the
stress was not sufficiently severe to cause changes in these
parameters. On recovery of Trec 37 C from C-H-R exposure-
induced hypothermia, the CAT values remained low but SOD
showed an increase, which was reflected in normalized plasma
MDA levels. The L-arginine (100 mg/kg body weight) admin-
istration resulted in decreased MDA levels, lower than in unex-
posed animals, both on attaining Trec 23 C during C-H-R
exposure and on recovery of Trec 37 C. The observed decrease
in oxidative stress was due to the better maintained CAT activ-
ity and increased SOD levels on attaining Trec 23 C and on
recovery of Trec 37 C. This suggested an anti-oxidant effect of
L-arginine administration. Lubec et al. (27) also reported sim-
ilar findings of reduced lipid peroxidation product MDA in
diabetic patients treated with L-arginine.
Exposure to stressful conditions increased cell membrane
permeability, indicating cellular membrane damage. Herbert (28)
observed altered cell membrane permeability as evidenced by
a significant increase in circulating creatine phosphokinase
(CPK) levels in rats restrained at 4 C for 2 h, and this increase
correlated with the changes in rectal temperature. In the pres-
ent study, blood LDH levels in control rats also increased,
by 58 and 105% on attaining Trec 23 C and on recovery ofeCAM 2005;2(1) 97
Trec 37 C, respectively, in comparison with unexposed rats. In
the rats treated with L-arginine (100 mg/kg body weight), the
increase in LDH levels both on attaining Trec 23 C and on
recovery of Trec 37 C were less than in control rats. This sug-
gested that L-arginine supplementation was acting at a cellular
level in maintaining the energy-dependent process of mem-
brane permeability.
NO, a potent vasodilator, has also been shown to be involved
in the enhancement of the thermogenic function of brown adi-
pose tissue in rats (15). In the present study, no significant
change was observed in blood NO levels in L-arginine-treated
rats that were exposed to C-H-R stress.
Increased circulating testosterone levels have been reported
in the organisms that are able to adapt successfully in stressful
situations, while decreased testosterone levels are indicative of
an organism’s loss of control or a defeat reaction during stress
(29). In the present study, a significant decrease in testosterone
levels was also observed in control rats exposed to Trec 23 C,
which decreased further on recovery to Trec 37 C. L-Arginine
supplementation showed no significant effect on testosterone
levels on Trec 23 C during C-H-R exposure and recovery to
Trec 37 C in comparison with control rats.
The result of the present study suggested that in rats the least
effective anti-stress and adaptogenic dose of L-arginine sup-
plementation was 100 mg/kg body weight. The observed anti-
stress activity of L-arginine was due to its anti-oxidative
effects, i.e. better maintained anti-oxidants (SOD and cata-
lase), reduced lipid peroxidation (MDA) and a lower increase
in blood LDH levels.
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